Home/Cayuga Biotech/Herb Brinkman, PhD

HB

Herb Brinkman, PhD

Head of CMC

Therapeutic Areas

Hemorrhage Control Coagulation Disorders

Cayuga Biotech Pipeline

Drug	Indication	Phase
CAY001	Life-threatening Hemorrhage (e.g., trauma, surgery, anticoagulant-related)	Pre-clinical

Leadership Team at Cayuga Biotech

Andrea Ashford-Hicks

Chief Executive Officer

Damien Kudela, PhD

Founder, Chief Science Officer

Corporate and Business Affairs

Head of Clinical Operations

Head of Translational Medicine

View full Cayuga Biotech profile